Skip to main content
Top
Published in: International Urogynecology Journal 3/2019

01-03-2019 | Original Article

Survey of pelvic reconstructive surgeons on performance of opportunistic salpingectomy at the time of pelvic organ prolapse repair

Authors: Daisy B. Hassani, Jeffrey M. Mangel, Sangeeta T. Mahajan, Adonis K. Hijaz, Sherif El-Nashar, David Sheyn

Published in: International Urogynecology Journal | Issue 3/2019

Login to get access

Abstract

Introduction and hypothesis

Opportunistic salpingectomy (OS) at the time of benign hysterectomy has recently emerged as a potential primary preventive modality for ovarian cancer. Our objective was to determine whether the reported rate of OS at the time of prolapse surgery is similar to the rate of OS at the time of gynecologic surgery for non-prolapse indications.

Methods

An anonymous online survey was sent to the Society of Gynecologic Surgery members. Responses were divided into surgeons who did and did not perform OS at the time of prolapse repair. Differences between surgeons who did and did not perform OS were evaluated using the chi-square test. Multivariable logistic regression was used to identify which responses related to increased odds of performing OS.

Results

There were 117 (33.1%) completed responses; of these, 98 (83.8%) reported performing OS at the time of prolapse repair, which was similar to the reported rate of OS at the time of hysterectomy for non-prolapse indications, 82.1%. After multivariable logistic regression, performance of salpingectomy at the time of hysterectomy for a non-prolapse indication (aOR: 17.9, 95% CI: 3.11–42.01), use of a laparoscopic or robotic surgical approach (aOR 14.1, 95% CI: 1.81–32.21) and completion of an FPMRS fellowship (aOR: 3.47, 95% CI: 1.20–10.02) were associated with a higher likelihood of performing OS at the time of prolapse repair.

Conclusions

OS at the time prolapse repair is performed more frequently with concomitant hysterectomy compared with OS at the time of post-hysterectomy prolapse repair and is similar to rates of OS performed at the time of hysterectomy for non-prolapse indications.
Literature
1.
go back to reference United States Cancer Statistics: 1999–2014 Incidence and Mortality Web-based Report. Accessed November 25, 2017. United States Cancer Statistics: 1999–2014 Incidence and Mortality Web-based Report. Accessed November 25, 2017.
3.
go back to reference Menon U, Kalsi J, Jacobs I. The UKCTOCS experience—reasons for hope? Int J Gynecol Cancer. 2012;22:S18–20.CrossRefPubMed Menon U, Kalsi J, Jacobs I. The UKCTOCS experience—reasons for hope? Int J Gynecol Cancer. 2012;22:S18–20.CrossRefPubMed
4.
go back to reference Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, et al. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial. JAMA. 2011;305(22):2295–303.CrossRefPubMed Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, et al. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial. JAMA. 2011;305(22):2295–303.CrossRefPubMed
5.
go back to reference Salvador S, Gilks B, Köbel M, Huntsman D, Rosen B, Miller D. The fallopian tube: primary site of most pelvic high-grade serous carcinomas. Int J Gynecol Cancer. 2009;19(1):58–64.CrossRefPubMed Salvador S, Gilks B, Köbel M, Huntsman D, Rosen B, Miller D. The fallopian tube: primary site of most pelvic high-grade serous carcinomas. Int J Gynecol Cancer. 2009;19(1):58–64.CrossRefPubMed
6.
go back to reference Salvador S, Rempel A, Soslow RA, Gilks B, Huntsman D, Miller D. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma. Gynecol Oncol. 2008;110(3):408–17.CrossRefPubMed Salvador S, Rempel A, Soslow RA, Gilks B, Huntsman D, Miller D. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma. Gynecol Oncol. 2008;110(3):408–17.CrossRefPubMed
7.
go back to reference Leeper K, Garcia R, Swisher E, Goff B, Greer B, Paley P. Pathologic findings in prophylactic oophorectomy specimens in high-risk women. Gynecol Oncol. 2002;87(1):52–6.CrossRefPubMed Leeper K, Garcia R, Swisher E, Goff B, Greer B, Paley P. Pathologic findings in prophylactic oophorectomy specimens in high-risk women. Gynecol Oncol. 2002;87(1):52–6.CrossRefPubMed
8.
go back to reference Colgan TJ, Murphy J, Cole DE, Narod S, Rosen B. Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status. Am J Surg Pathol. 2001;25(10):1283–9.CrossRefPubMed Colgan TJ, Murphy J, Cole DE, Narod S, Rosen B. Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status. Am J Surg Pathol. 2001;25(10):1283–9.CrossRefPubMed
9.
go back to reference Kindelberger DW, Lee Y, Miron A, Hirsch MS, Feltmate C, Medeiros F, et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol. 2007;31(2):161–9.CrossRefPubMed Kindelberger DW, Lee Y, Miron A, Hirsch MS, Feltmate C, Medeiros F, et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol. 2007;31(2):161–9.CrossRefPubMed
10.
go back to reference Crum CP, Drapkin R, Kindelberger D, Medeiros F, Miron A, Lee Y. Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. Clin Med Res. 2007;5(1):35–44.CrossRefPubMedPubMedCentral Crum CP, Drapkin R, Kindelberger D, Medeiros F, Miron A, Lee Y. Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. Clin Med Res. 2007;5(1):35–44.CrossRefPubMedPubMedCentral
11.
go back to reference Gaitskell K, Coffey K, Green J, Pirie K, Reeves GK, Ahmed AA, et al. Tubal ligation and incidence of 26 site-specific cancers in the million women study. Br J Cancer. 2016;114:1033–7.CrossRefPubMedPubMedCentral Gaitskell K, Coffey K, Green J, Pirie K, Reeves GK, Ahmed AA, et al. Tubal ligation and incidence of 26 site-specific cancers in the million women study. Br J Cancer. 2016;114:1033–7.CrossRefPubMedPubMedCentral
12.
go back to reference Rice MS, Hankinson SE, Tworoger SS. Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the nurses’ health studies. Fertil Steril. 2014;102(1):192–8.CrossRefPubMedPubMedCentral Rice MS, Hankinson SE, Tworoger SS. Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the nurses’ health studies. Fertil Steril. 2014;102(1):192–8.CrossRefPubMedPubMedCentral
13.
go back to reference Mikhail E, Salemi JL, Mogos MF, Hart S, Salihu HM, Imudia AN. National trends of adnexal surgeries at the time of hysterectomy for benign indication, United States, 1998–2011. Am J Obstet Gynecol. 2015;213(5):713–e1.CrossRefPubMed Mikhail E, Salemi JL, Mogos MF, Hart S, Salihu HM, Imudia AN. National trends of adnexal surgeries at the time of hysterectomy for benign indication, United States, 1998–2011. Am J Obstet Gynecol. 2015;213(5):713–e1.CrossRefPubMed
14.
go back to reference Gill SE, Mills BB. Physician opinions regarding elective bilateral salpingectomy with hysterectomy and for sterilization. J Minim Invasive Gynecol. 2013;20(4):517–21.CrossRefPubMed Gill SE, Mills BB. Physician opinions regarding elective bilateral salpingectomy with hysterectomy and for sterilization. J Minim Invasive Gynecol. 2013;20(4):517–21.CrossRefPubMed
15.
go back to reference Jones NL, Schulkin J, Urban RR, Wright JD, Burke WM, Hou JY, et al. Physicians’ perspectives and practice patterns toward opportunistic salpingectomy in high-and low-risk women. Cancer Investig. 2017;35(1):51–61.CrossRef Jones NL, Schulkin J, Urban RR, Wright JD, Burke WM, Hou JY, et al. Physicians’ perspectives and practice patterns toward opportunistic salpingectomy in high-and low-risk women. Cancer Investig. 2017;35(1):51–61.CrossRef
16.
go back to reference Jones KA, Shepherd JP, Oliphant SS, Wang L, Bunker CH, Lowder JL. Trends in inpatient prolapse procedures in the United States, 1979–2006. Am J Obstet Gynecol. 2010;202(5):501–e1.CrossRefPubMedPubMedCentral Jones KA, Shepherd JP, Oliphant SS, Wang L, Bunker CH, Lowder JL. Trends in inpatient prolapse procedures in the United States, 1979–2006. Am J Obstet Gynecol. 2010;202(5):501–e1.CrossRefPubMedPubMedCentral
17.
go back to reference Potz FL, Tomasch G, Polterauer S, Laky R, Marth C, Tamussino K. Incidental (prophylactic) salpingectomy at benign gynecologic surgery and cesarean section: a survey of practice in Austria. Geburtshilfe Frauenheilkd. 2016;76(12):1325–9.CrossRefPubMedPubMedCentral Potz FL, Tomasch G, Polterauer S, Laky R, Marth C, Tamussino K. Incidental (prophylactic) salpingectomy at benign gynecologic surgery and cesarean section: a survey of practice in Austria. Geburtshilfe Frauenheilkd. 2016;76(12):1325–9.CrossRefPubMedPubMedCentral
18.
go back to reference Kapurubandara S, Qin V, Gurram D, Anpalagan A, Merkur H, Hogg R, et al. Opportunistic bilateral salpingectomy during gynaecological surgery for benign disease: a survey of current Australian practice. Aust N Z J Obstet Gynaecol. 2015;55(6):606–11.CrossRefPubMed Kapurubandara S, Qin V, Gurram D, Anpalagan A, Merkur H, Hogg R, et al. Opportunistic bilateral salpingectomy during gynaecological surgery for benign disease: a survey of current Australian practice. Aust N Z J Obstet Gynaecol. 2015;55(6):606–11.CrossRefPubMed
19.
go back to reference Venturella R, Rocca M, Lico D, Trapasso S, Di Cello A, Gizzo S, et al. Prophylactic bilateral salpingectomy for the prevention of ovarian cancers: what is happening in Italy? Eur J Cancer Prev. 2016;25(5):410–5.CrossRefPubMed Venturella R, Rocca M, Lico D, Trapasso S, Di Cello A, Gizzo S, et al. Prophylactic bilateral salpingectomy for the prevention of ovarian cancers: what is happening in Italy? Eur J Cancer Prev. 2016;25(5):410–5.CrossRefPubMed
20.
go back to reference Robert M, Cenaiko D, Sepandj J, Iwanicki S. Success and complications of salpingectomy at the time of vaginal hysterectomy. J Minim Invasive Gynecol. 2015;22(5):864–9.CrossRefPubMed Robert M, Cenaiko D, Sepandj J, Iwanicki S. Success and complications of salpingectomy at the time of vaginal hysterectomy. J Minim Invasive Gynecol. 2015;22(5):864–9.CrossRefPubMed
21.
go back to reference Bradley MS, Visco AG. Role of salpingectomy at the time of urogynecologic surgery. Curr Opin Obstet Gynecol. 2015;27(5):385–9.CrossRefPubMed Bradley MS, Visco AG. Role of salpingectomy at the time of urogynecologic surgery. Curr Opin Obstet Gynecol. 2015;27(5):385–9.CrossRefPubMed
22.
go back to reference Lamblin G, Meysonnier C, Moret S, Nadaud B, Mellier G, Chene G. Opportunistic salpingectomy during vaginal hysterectomy for a benign pathological condition. Int Urogynecol J. 2017;1-7. Lamblin G, Meysonnier C, Moret S, Nadaud B, Mellier G, Chene G. Opportunistic salpingectomy during vaginal hysterectomy for a benign pathological condition. Int Urogynecol J. 2017;1-7.
23.
go back to reference Kho RM, Wechter ME. Operative outcomes of opportunistic bilateral salpingectomy at the time of benign hysterectomy in low-risk premenopausal women: a systematic review. J Minim Invasive Gynecol. 2017;24(2):218–29.CrossRefPubMed Kho RM, Wechter ME. Operative outcomes of opportunistic bilateral salpingectomy at the time of benign hysterectomy in low-risk premenopausal women: a systematic review. J Minim Invasive Gynecol. 2017;24(2):218–29.CrossRefPubMed
24.
go back to reference Antosh DD, High R, Brown HW, Oliphant SS, Abed H, Philip N, et al. Feasibility of prophylactic salpingectomy during vaginal hysterectomy. Am J Obstet Gynecol. 2017;217(5):605–e1.CrossRefPubMedPubMedCentral Antosh DD, High R, Brown HW, Oliphant SS, Abed H, Philip N, et al. Feasibility of prophylactic salpingectomy during vaginal hysterectomy. Am J Obstet Gynecol. 2017;217(5):605–e1.CrossRefPubMedPubMedCentral
25.
go back to reference Garcia C, Martin M, Tucker LY, Lyon L, Armstrong MA, McBride-Allen S, et al. Experience with opportunistic salpingectomy in a large, community-based health system in the United States. Obstet Gynecol. 2016;128(2):277–83. Garcia C, Martin M, Tucker LY, Lyon L, Armstrong MA, McBride-Allen S, et al. Experience with opportunistic salpingectomy in a large, community-based health system in the United States. Obstet Gynecol. 2016;128(2):277–83.
26.
go back to reference Van Lieshout LA, Pijlman B, Vos MC, de Groot MJ, Houterman S, Coppus SF, et al. Opportunistic salpingectomy in women undergoing hysterectomy: results from the HYSTUB randomised controlled trial. Maturitas. 2018;107:1–6.CrossRefPubMed Van Lieshout LA, Pijlman B, Vos MC, de Groot MJ, Houterman S, Coppus SF, et al. Opportunistic salpingectomy in women undergoing hysterectomy: results from the HYSTUB randomised controlled trial. Maturitas. 2018;107:1–6.CrossRefPubMed
27.
go back to reference Tehranian A, Zangbar RH, Aghajani F, Sepidarkish M, Rafiei S, Esfidani T. Effects of salpingectomy during abdominal hysterectomy on ovarian reserve: a randomized controlled trial. Gynecol Surg. 2017;14(1):17.CrossRefPubMedPubMedCentral Tehranian A, Zangbar RH, Aghajani F, Sepidarkish M, Rafiei S, Esfidani T. Effects of salpingectomy during abdominal hysterectomy on ovarian reserve: a randomized controlled trial. Gynecol Surg. 2017;14(1):17.CrossRefPubMedPubMedCentral
28.
go back to reference Mohamed AA, Yosef AH, James C, Al-Hussaini TK, Bedaiwy MA, Amer SA. Ovarian reserve after salpingectomy: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2017. Mohamed AA, Yosef AH, James C, Al-Hussaini TK, Bedaiwy MA, Amer SA. Ovarian reserve after salpingectomy: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2017.
29.
go back to reference Jones K, Wang G, Romano R, St Marie P, Harmanli O. Colpocleisis: a survey of current practice patterns. Female Pelvic Med Reconstr Surg. 2017;23(4):276–80.CrossRefPubMedPubMedCentral Jones K, Wang G, Romano R, St Marie P, Harmanli O. Colpocleisis: a survey of current practice patterns. Female Pelvic Med Reconstr Surg. 2017;23(4):276–80.CrossRefPubMedPubMedCentral
30.
go back to reference Mikami M, Nagase S, Yamagami W, Ushijma K, Tashiro H, Katabuchi H. Opportunistic bilateral salpingectomy during benign gynecological surgery for ovarian cancer prevention: a survey of gynecologic oncology committee of japan society of obstetrics and gynecology. J Gynecol Oncol. 2017;28(4). Mikami M, Nagase S, Yamagami W, Ushijma K, Tashiro H, Katabuchi H. Opportunistic bilateral salpingectomy during benign gynecological surgery for ovarian cancer prevention: a survey of gynecologic oncology committee of japan society of obstetrics and gynecology. J Gynecol Oncol. 2017;28(4).
31.
go back to reference Conrad LB, Ramirez PT, Burke W, Naumann RW, Ring KL, Munsell MF, et al. Role of minimally invasive surgery in gynecologic oncology: an updated survey of members of the society of gynecologic oncology. Int J Gynecol Cancer: Off J Int Gynecol Cancer Soc. 2015;25(6):1121.CrossRef Conrad LB, Ramirez PT, Burke W, Naumann RW, Ring KL, Munsell MF, et al. Role of minimally invasive surgery in gynecologic oncology: an updated survey of members of the society of gynecologic oncology. Int J Gynecol Cancer: Off J Int Gynecol Cancer Soc. 2015;25(6):1121.CrossRef
Metadata
Title
Survey of pelvic reconstructive surgeons on performance of opportunistic salpingectomy at the time of pelvic organ prolapse repair
Authors
Daisy B. Hassani
Jeffrey M. Mangel
Sangeeta T. Mahajan
Adonis K. Hijaz
Sherif El-Nashar
David Sheyn
Publication date
01-03-2019
Publisher
Springer International Publishing
Published in
International Urogynecology Journal / Issue 3/2019
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-018-3652-0

Other articles of this Issue 3/2019

International Urogynecology Journal 3/2019 Go to the issue